HÜRMÜZ, P. Et Al. 2020. Treatment outcomes of metastasis-directed treatment using 68 Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002). Türk Radyasyon Onkolojisi sanal Kongresi , (Turkey).

HÜRMÜZ, P., ÖNAL, H. C., ÖZYİĞİT, G., İĞDEM, M. Ş., ATALAR, B., sayan, h., ... Akgün, Z.(2020). Treatment outcomes of metastasis-directed treatment using 68 Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002) . Türk Radyasyon Onkolojisi sanal Kongresi, Turkey

HÜRMÜZ, PERVİN Et Al. "Treatment outcomes of metastasis-directed treatment using 68 Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)," Türk Radyasyon Onkolojisi sanal Kongresi, Turkey, 2020

HÜRMÜZ, PERVİN Et Al. "Treatment outcomes of metastasis-directed treatment using 68 Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)." Türk Radyasyon Onkolojisi sanal Kongresi , Turkey, 2020

HÜRMÜZ, P. Et Al. (2020) . "Treatment outcomes of metastasis-directed treatment using 68 Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)." Türk Radyasyon Onkolojisi sanal Kongresi , Turkey.

@conferencepaper{conferencepaper, author={PERVİN HÜRMÜZ Et Al. }, title={Treatment outcomes of metastasis-directed treatment using 68 Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)}, congress name={Türk Radyasyon Onkolojisi sanal Kongresi}, city={}, country={Turkey}, year={2020}}